Federal judge refuses to pause suit over Unison’s home equity product
She now argues the opposite. Strip away “deliberately complex accounting, lengthy and convoluted contracts, and opaque terminology,” her complaint says, and “Unison’s product is a loan.” She claims the company “obfuscate[s] the true nature of its transaction,” and that calling the deal something other than a mortgage violated the D.C. Consumer Protection Procedures Act.
Unison tells a different story. In its briefing, the company describes an equity-sharing agreement: “upfront capital with no monthly payments, no interest accrual, and virtually no likelihood of foreclosure in return for the option to buy a partial interest in [the] property in the future for a set price.”
To win a pause, Unison pointed to a parallel suit the National Association of Consumer Advocates filed in D.C. Superior Court on February 11, 2026, pressing similar claims. It invoked two abstention doctrines and the court’s own power to manage its docket. The judge rejected all three, finding no “exceptional circumstances” and noting both cases sat at the same early stage.
What matters most to lenders is the question left open. The homeowner wants the court to remove the deed of trust she says is “clouding the title” to her home. A finding that a home equity option works like a mortgage would reach every firm selling these products.
That answer is a long way off. No court has found that Unison’s product is a loan, that it misled anyone, or that it broke any law, and Unison has yet to answer the underlying claims.
